Celltrion
068270.KS
#676
Rank
A$52.62 B
Marketcap
A$240.55
Share price
-1.61%
Change (1 day)
27.77%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.66. In 2024 the company made an earnings per share (EPS) of A$1.88 a decrease over its 2023 EPS that were of A$3.74.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$2.8852.81%
2024A$1.88-49.57%
2023A$3.74-2.08%
2022A$3.82-11.72%
2021A$4.322.03%
2020A$4.2482.8%
2019A$2.3218.31%
2018A$1.96-36.33%
2017A$3.08161.25%
2016A$1.182.86%
2015A$1.1417.84%
2014A$0.975.87%
2013A$0.92-70.85%
2012A$3.15134.09%
2011A$1.3443.59%
2010A$0.9474.49%
2009A$0.54317.8%
2008A$0.13-71.7%
2007A$0.45